Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Gatanaga

Showing results (1-10 of 274) with videos related to

Pageof 28
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 24, 2002
[Clinical impact of combination antiretroviral therapy]Hiroyuki Gatanaga
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 10, 2012
[New anti-HIV agents]Hiroyuki Gatanaga
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 17, 2010
[Integrase inhibitor, CCR5 antagonist, fusion inhibitor]Hiroyuki Gatanaga
Global Health & Medicine|November 1, 2024
Advances in HIV management and challenges in Japan: Current situation of pre-exposure prophylaxis in TokyoDaisuke Mizushima, Hiroyuki Gatanaga, Shinichi Oka
Global Health & Medicine|November 1, 2024
Sexual health care barriers and HIV/STI prevention for transgender people in JapanShin Ikebukuro, Daisuke Shiojiri, Hiroyuki Gatanaga
Global Health & Medicine|December 17, 2020
Tenofovir nephrotoxicity among Asians living with HIV: review of the literatureTakeshi Nishijima, Hiroyuki Gatanaga, Shinichi Oka
Pharmacogenomics|March 29, 2008
Pharmacogenetic information derived from analysis of HLA allelesHiroyuki Gatanaga, Haruhito Honda, Shinichi Oka
AIDS Research and Human Retroviruses|March 11, 2008
Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassayTsunefusa Hayashida, Hiroyuki Gatanaga, Junko Tanuma, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 29, 2026
Prevalence and clinical characteristics of HIV/sexually transmitted infections among transgender and gender-diverse individuals attending a gender-affirming clinic in Japan: A descriptive clinical-based studyShin Ikebukuro, Daisuke Shiojiri, Akira Kawashima, et al.
Global Health & Medicine|November 1, 2024
Identification of new circulating recombinant form of HIV-1 CRF139_02B in Japan, and search for the originTsunefusa Hayashida, Kiyoto Tsuchiya, Shinichi Oka, et al.
Pageof 28

Showing results (1-10 of 274) with videos related to

Sort By:
Pageof 28
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 24, 2002
[Clinical impact of combination antiretroviral therapy]Hiroyuki Gatanaga
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 10, 2012
[New anti-HIV agents]Hiroyuki Gatanaga
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 17, 2010
[Integrase inhibitor, CCR5 antagonist, fusion inhibitor]Hiroyuki Gatanaga
Global Health & Medicine|November 1, 2024
Advances in HIV management and challenges in Japan: Current situation of pre-exposure prophylaxis in TokyoDaisuke Mizushima, Hiroyuki Gatanaga, Shinichi Oka
Global Health & Medicine|November 1, 2024
Sexual health care barriers and HIV/STI prevention for transgender people in JapanShin Ikebukuro, Daisuke Shiojiri, Hiroyuki Gatanaga
Global Health & Medicine|December 17, 2020
Tenofovir nephrotoxicity among Asians living with HIV: review of the literatureTakeshi Nishijima, Hiroyuki Gatanaga, Shinichi Oka
Pharmacogenomics|March 29, 2008
Pharmacogenetic information derived from analysis of HLA allelesHiroyuki Gatanaga, Haruhito Honda, Shinichi Oka
AIDS Research and Human Retroviruses|March 11, 2008
Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassayTsunefusa Hayashida, Hiroyuki Gatanaga, Junko Tanuma, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 29, 2026
Prevalence and clinical characteristics of HIV/sexually transmitted infections among transgender and gender-diverse individuals attending a gender-affirming clinic in Japan: A descriptive clinical-based studyShin Ikebukuro, Daisuke Shiojiri, Akira Kawashima, et al.
Global Health & Medicine|November 1, 2024
Identification of new circulating recombinant form of HIV-1 CRF139_02B in Japan, and search for the originTsunefusa Hayashida, Kiyoto Tsuchiya, Shinichi Oka, et al.
Pageof 28